Capital World Investors Increases Stock Position in Veeva Systems Inc. $VEEV

Key Points

• Capital World Investors increased its stake in Veeva Systems by 2.0% to 669,679 shares (about $199.5 million), representing roughly 0.41% of the company.
• Veeva beat Q4 estimates with $2.06 EPS and $835.95M in revenue (up 16% year-over-year) and its board approved a $2.00 billion buyback program to repurchase up to 5.5% of outstanding shares.
• Analysts remain generally favorable with an average rating of Moderate Buy and a $283.70 target, though some firms have trimmed targets recently; insider Thomas D. Schwenger sold 1,000 shares, and insiders own about 10.3% of the stock.

Capital World Investors boosted its holdings in Veeva Systems Inc. (NYSE:VEEV - Free Report) by 2.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 669,679 shares of the technology company's stock after buying an additional 13,272 shares during the period. Capital World Investors owned approximately 0.41% of Veeva Systems worth $199,504,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of VEEV. GPS Wealth Strategies Group LLC lifted its holdings in Veeva Systems by 196.4% during the 3rd quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company's stock worth $25,000 after purchasing an additional 55 shares in the last quarter. Raiffeisen Bank International AG purchased a new stake in shares of Veeva Systems in the third quarter worth about $28,000. OLD Second National Bank of Aurora bought a new position in shares of Veeva Systems in the third quarter valued at approximately $30,000. Cary Street Partners Investment Advisory LLC boosted its position in shares of Veeva Systems by 58.3% in the second quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company's stock valued at $38,000 after acquiring an additional 49 shares during the period. Finally, Elevation Point Wealth Partners LLC purchased a new position in Veeva Systems during the second quarter valued at approximately $41,000. Institutional investors own 88.20% of the company's stock.

Insider Transactions at Veeva Systems

In related news, insider Thomas D. Schwenger sold 1,000 shares of the firm's stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $231.43, for a total transaction of $231,430.00. Following the transaction, the insider directly owned 23,204 shares in the company, valued at $5,370,101.72. This trade represents a 4.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 10.30% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several analysts have issued reports on VEEV shares. UBS Group increased their target price on shares of Veeva Systems from $200.00 to $220.00 and gave the stock a "neutral" rating in a research note on Thursday, March 5th. Oppenheimer reduced their price target on shares of Veeva Systems from $325.00 to $275.00 and set an "outperform" rating for the company in a research report on Tuesday, February 24th. JPMorgan Chase & Co. decreased their price target on shares of Veeva Systems from $330.00 to $296.00 and set an "overweight" rating on the stock in a report on Friday, February 20th. Barclays lowered their price objective on Veeva Systems from $305.00 to $250.00 and set an "overweight" rating on the stock in a research report on Wednesday, February 25th. Finally, Robert W. Baird boosted their target price on Veeva Systems from $314.00 to $319.00 and gave the stock an "outperform" rating in a research report on Friday, November 21st. Seventeen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $283.70.

Veeva Systems Stock Performance

Shares of Veeva Systems stock opened at $186.96 on Thursday. Veeva Systems Inc. has a 52-week low of $168.13 and a 52-week high of $310.50. The company has a fifty day moving average of $201.48 and a 200-day moving average of $245.18. The stock has a market capitalization of $30.73 billion, a price-to-earnings ratio of 34.56, a price-to-earnings-growth ratio of 1.31 and a beta of 1.09.

Veeva Systems (NYSE:VEEV - Get Free Report) last issued its earnings results on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, topping analysts' consensus estimates of $1.94 by $0.12. The company had revenue of $835.95 million for the quarter, compared to analysts' expectations of $810.95 million. Veeva Systems had a net margin of 28.44% and a return on equity of 14.11%. The firm's revenue was up 16.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.74 EPS. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, equities research analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Veeva Systems announced that its board has initiated a stock buyback program on Monday, January 5th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the technology company to purchase up to 5.5% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's board of directors believes its shares are undervalued.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva acquired AI chat specialist Ostro for roughly $100M to add an AI-driven, compliant brand‑engagement chat tool for patients and HCPs — expands Commercial Cloud capabilities and product moat. Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
• Positive Sentiment: AOP Health standardized on Veeva’s Industry Cloud across R&D, quality, commercial and data — a notable customer win that supports recurring SaaS revenue and cross‑cloud adoption. AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas
• Positive Sentiment: Q4 results beat expectations with stronger demand for modernization (safety, R&D) and expansion among top 20 pharma customers; management emphasized scalable, automated core systems as the main growth driver. These fundamentals support revenue durability and the long‑term SaaS upsell story. 5 Revealing Analyst Questions From Veeva Systems’s Q4 Earnings Call
• Neutral Sentiment: Analyst/investor attention articles (Zacks, market commentary) highlight interest in Veeva but don’t add new material facts — they may increase trading volume but are unlikely alone to change fundamentals. Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
• Negative Sentiment: Citigroup lowered its expectations/price target for Veeva, signaling analyst concern that recent moves (acquisition spend, guidance cadence) or valuation may not justify current multiples — analyst downgrades can pressure the stock near term. Citigroup Has Lowered Expectations for Veeva Systems NYSE: VEEV Stock Price

Veeva Systems Company Profile

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.